- Home
- KNSA vs CIGI Comparison
KNSA vs CIGI Comparison
Compare KNSA & CIGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KNSA | CIGI |
|---|---|---|
| Founded | 2015 | 1972 |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.3B |
| IPO Year | 2018 | 1995 |
Fundamental Metrics
Financial Performance| Metric | KNSA | CIGI |
|---|---|---|
| Price | $76.63 | $93.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | $60.86 | ★ $176.25 |
| AVG Volume (30 Days) | ★ 428.4K | 198.5K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.29% |
| EPS Growth | ★ 225.00 | N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $677,564,000.00 | N/A |
| Revenue This Year | $37.48 | $17.28 |
| Revenue Next Year | $17.87 | $8.30 |
| P/E Ratio | $290.81 | ★ $57.57 |
| Revenue Growth | ★ 60.09 | N/A |
| 52 Week Low | $35.29 | $88.38 |
| 52 Week High | $82.94 | $171.20 |
Technical Indicators
Market Signals| Indicator | KNSA | CIGI |
|---|---|---|
| Relative Strength Index (RSI) | 48.49 | 34.04 |
| Support Level | $44.95 | $91.10 |
| Resistance Level | $82.25 | $101.53 |
| Average True Range (ATR) | 2.37 | 2.87 |
| MACD | -0.80 | -1.45 |
| Stochastic Oscillator | 19.36 | 5.95 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
About CIGI Colliers International Group Inc. Subordinate Voting Shares
Colliers International Group Inc provides commercial real estate professional services and investment management to corporate and institutional clients across different countries around the world. Its operating segments are Commercial Real Estate, Engineering and Investment Management. Maximum revenue for the company is generated from its Commercial Real Estate segment, which offers services like transaction and debt finance services, outsourcing in property management, valuation and advisory, loan servicing, and others. Geographically, the company generates maximum revenue from the United States followed by Canada, Euro currency countries, Australia, the United Kingdom, Poland, China, India, and other regions.